期刊
NANO RESEARCH
卷 15, 期 4, 页码 3422-3433出版社
TSINGHUA UNIV PRESS
DOI: 10.1007/s12274-021-3948-0
关键词
synergetic lethality; energy depletion; mitochondria-targeting; mitochondrial oxidative phosphorylation; glycolysis
类别
资金
- National Natural Science Foundation of China [81773656]
- Liaoning Revitalization Talents Program [XLYC1808017]
- Shenyang Youth Science and Technology Innovation Talents Program [RC190454]
- National Postdoctoral Foundation of China [2021M693868]
Mitochondrial bioenergy plays a vital role in cancer occurrence and development. The study presents a cancer cell membrane camouflaged nano-inhibitor that can block two different energy pathways and exhibit precision tumor-targeting. Under laser irradiation, the nano-inhibitor inhibits oxidative phosphorylation and reduces tumor energy, significantly suppressing tumor growth.
Mitochondrial bioenergy plays a vital role in the occurrence and development of cancer. Although strategies to impede mitochondrial energy supply have been rapidly developed, the anticancer efficacy is still far from satisfactory, mainly attributed to the hybrid metabolic pathways of mitochondrial oxidative phosphorylation (OXPHOS) and glycolysis. Herein, we construct a cancer cell membrane camouflaged nano-inhibitor, mTPPa-Sy nanoparticle (NP), which co-encapsulates OXPHOS inhibitor (mitochondrial-targeting photosensitizers: TPPa) and glycolysis inhibitor (syrosingopine (Sy)) for synergistically blocking the two different energy pathways. The mTPPa-Sy NPs exhibit precision tumor-targeting due to the high affinity between the biomimic membrane and the homotypic cancer cells. Under laser irradiation, the mitochondrial-targeting TPPa, which is synthesized by conjugating pyropheophorbide a (PPa) with triphenylphosphin, produces excessive reactive oxygen species (ROS) and further disrupts the OXPHOS. Interestingly, OXPHOS inhibition reduces O-2 consumption and improves ROS production, further constructing a closed-loop OXPHOS inhibition system. Moreover, TPPa-initiated OXPHOS inhibition in combination with the Sy-triggered glycolysis inhibition results in lethal energy depletion, significantly suppressing tumor growth even after a single treatment. Our findings highlight the necessity and effectiveness of synergetic lethal energy depletion, providing a prospective strategy for efficient cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据